logo image
search icon
Oral Solid Dosage Contract Manufacturing Market

Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Tablets, Capsules, Powders, Granules), Mechanism (Immediate-Release, Delayed-Release, And Controlled-Release), And End-User (Large-Size Companies, Medium- & Small-Size Companies), Region And Segment Forecasts, 2023-2031

Report ID : 1814 | Published : 2024-04-01 | Pages: 180 | Format: PDF/EXCEL

The Oral Solid Dosage Contract Manufacturing Market Size is valued at 32.36 billion in 2022 and is predicted to reach 52.60 billion by the year 2031 at a 5.72% CAGR during the forecast period for 2023-2031.

Oral Solid Dosage Contract Manufacturing are the complexity of new drug compounds will all contribute to the market's expansion. Because they are affordable, easy to produce, and convenient for patients, oral solids are the dosage forms that are most commonly used in the pharmaceutical industry. Oral solids can now attain even better levels of bioavailability while requiring less frequent medication administration because of developments in drug delivery technology, including the distribution of pharmaceuticals and sustained-release formulation. The most fundamental forms of solid dosage forms are tablets and capsules.

Oral Solid Dosage Contract Manufacturing Market

To improve patient compliance, businesses are already utilizing cutting-edge technologies to increase the bioavailability of dose forms. Contract manufacturers for oral solid dosage forms launch or improve new products. Increased investments in infrastructure development, plant expansions, and CDMO capabilities to offer fully integrated services will boost the contract development and manufacturing industry over the coming years. 

Competitive Landscape:

Some of the Oral Solid Dosage Contract Manufacturing market players are:

  • Catalent Inc
  • Lonza Group
  • Piramal Pharma Solutions
  • Aenova
  • Jubilant
  • Boehringer Ingelheim
  • AbbVie Contract Manufacturing
  • Patheon
  • Recipharm
  • Next Pharma AB
  • Siegfried AG
  • Corden Pharma 

Market Segmentation:

The Oral Solid Dosage Contract Manufacturing market is categorized on the basis of product type, mechanism, and end-user. The product type segment includes tablets, capsules, powders, granules, and others (lozenges, gummies, pastilles, etc.). The mechanism segment includes immediate-release, delayed-release, and controlled-release. By end-user, the market is segmented into large-size companies, medium- & small-size companies, and others (startups & generic pharmaceutical companies).

Based On Product Type Outlook, The Tablet And Capsule Segment Is Accounted As A Significant Contributor In The Oral Solid Dosage Contract Manufacturing Market

The tablet and capsule category is expected to hold a major share of the global Oral Solid Dosage Contract Manufacturing market. This can be ascribed to the portability, simplicity in ingesting, good absorption, and medical adherence that various dose forms offer. Due to their expanded capabilities and enormous production capacities, established businesses (with over 10,000 employees) are also projected to hold over 50% of the current and future market in terms of company size.

The Controlled-Release Segment Witnessed Growth At A Rapid Rate

The market has been divided into three types based on mechanisms: controlled-release, delayed-release, and immediate-release. In 2022, the controlled-release mechanism market category had a maximum revenue share. During the projected period, the segment is also anticipated to increase at the fastest rate. Drug developers can create medications that are kinder to patients while still being effective by altering the pace and/or location at which an API is released. Controlling the release of the API allows for a reduction in the number of dosages needed per day as well as the exclusion of variations in drug plasma levels, which often lead to fewer adverse effects.

Asia Pacific Oral Solid Dosage Contract Manufacturing Market Position Maintains A Significant Revenue Share In The Region

With a significant CAGR over the projection period, Asia Pacific is anticipated to keep the quickest rate of growth in the region. Additionally, the region held the most important market share in 2021. With much lower prices, India and China are the APAC region's OSD CMO market leaders. Manufacturing of generic drugs is the second-largest source of revenue in the APAC area due to rising patent expiration rates.

CMOs are also working to achieve ISO accreditation in energy use, quality management, and environmental management. Additionally, while the quantity of warning letters has fallen in developed countries, it has risen in Asia Pacific, and transgressions of cGMP production standards have brought on most recalls. In addition, due to investments made by local businesses and increased FDA drug approval, North America is the second-most lucrative area. 

Oral Solid Dosage Contract Manufacturing Market Report Scope:

Report Attribute

Specifications

Market size value in 2022

USD 32.36 Bn

Revenue forecast in 2031

USD 52.60 Bn

Growth rate CAGR

CAGR of 5.72 % from 2023 to 2031

Quantitative units

Representation of revenue in US$ Billion and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report coverage

The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends

Segments covered

Product Type, Mechanism, And End-User

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia

Competitive Landscape

Catalent Inc; Lonza Group; Piramal Pharma Solutions; Aenova; Jubilant; Boehringer Ingelheim; AbbVie Contract Manufacturing; Patheon; Recipharm; Next Pharma AB; Siegfried AG; Corden Pharma.

Customization scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and available payment methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Oral Solid Dosage Contract Manufacturing Market Snapshot

Chapter 4. Global Oral Solid Dosage Contract Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:

5.2.1. Tablets
5.2.2. Capsules
5.2.3. Powders
5.2.4. Granules
5.2.5. Others

Chapter 6. Market Segmentation 2: by Mechanism Estimates & Trend Analysis
6.1. by Mechanism & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Mechanism:

6.2.1. Immediate Release
6.2.2. Delayed Release
6.2.3. Controlled Release

Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis
7.1. by End-user & Market Share, 2019 & 2031

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:
7.2.1. Large Size Companies
7.2.2. Medium & Small Size Companies
7.2.3. Others

Chapter 8. Oral Solid Dosage Contract Manufacturing Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
8.1.2. North America Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Mechanism, 2023-2031
8.1.3. North America Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2023-2031
8.1.4. North America Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

8.2. Europe

8.2.1. Europe Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
8.2.2. Europe Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Mechanism, 2023-2031
8.2.3. Europe Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2023-2031
8.2.4. Europe Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
8.3.2. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Mechanism, 2023-2031
8.3.3. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2023-2031
8.3.4. Asia Pacific Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

8.4. Latin America

8.4.1. Latin America Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
8.4.2. Latin America Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Mechanism, 2023-2031
8.4.3. Latin America Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2023-2031
8.4.4. Latin America Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
8.5.2. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Mechanism, 2023-2031
8.5.3. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2023-2031
8.5.4. Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles


9.2.1. Catalent, Inc.
9.2.2. Lonza Group
9.2.3. Piramal Pharma Solutions
9.2.4. Aenova
9.2.5. Jubilant
9.2.6. Boehringer Ingelheim
9.2.7. AbbVie Contract Manufacturing
9.2.8. Patheon
9.2.9. Recipharm
9.2.10. Next Pharma AB
9.2.11. Siegfried AG
9.2.12. Corden Pharma
9.2.13. Other Prominent Players

Segmentation of Oral Solid Dosage Contract Manufacturing Market-

Oral Solid Dosage Contract Manufacturing Market By Product Type Outlook-

  • Tablets
  • Capsules
  • Powders
  • Granules
  • Others (Lozenges, Gummies, Pastilles, etc.)

Oral Solid Dosage Contract Manufacturing Market

Oral Solid Dosage Contract Manufacturing Market By Mechanism Outlook-

  • Immediate Release
  • Delayed Release
  • Controlled Release

Oral Solid Dosage Contract Manufacturing Market By End-user Outlook-

  • Large-size Companies
  • Medium- & Small-size Companies
  • Others (Startups & Generic Pharmaceutical Companies)

Oral Solid Dosage Contract Manufacturing Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

 InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Oral Solid Dosage Contract Manufacturing Market?

Oral Solid Dosage Contract Manufacturing Market expected to grow at a 5.72% CAGR during the forecast period for 2023-2031

Catalent Inc; Lonza Group; Piramal Pharma Solutions; Aenova; Jubilant; Boehringer Ingelheim; AbbVie Contract Manufacturing; Patheon; Recipharm; Next P

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach